Publications
Found 2 results
Filters: Author is J.L. Hu [Clear All Filters]
“Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair”, vol. 14, pp. 13437-13455, 2015.
, “An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus”, vol. 11, pp. 53-60, 2012.
, Aloman C and Wands JR (2003). Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy? Hepatology 38: 1584-1587.
http://dx.doi.org/10.1002/hep.510380633
PMid:14655682
Chan V, Yam I, Chen FE and Chan TK (1999). A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br. J. Haematol. 104: 513-515.
http://dx.doi.org/10.1046/j.1365-2141.1999.01221.x
PMid:10086788
Dai CY, Chuang WL, Hsieh MY and Lee LP (2007). Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res. 75: 146-151.
http://dx.doi.org/10.1016/j.antiviral.2007.02.003
PMid:17400303
Delaney WE (2007). Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil. J. Antimicrob. Chemother. 59: 827-832.
http://dx.doi.org/10.1093/jac/dkl551
PMid:17332007
Fung SK, Chae HB, Fontana RJ, Conjeevaram H, et al. (2006). Virologic response and resistance to adefovir in patients with chronic hepatitis B. J. Hepatol. 44: 283-290.
http://dx.doi.org/10.1016/j.jhep.2005.10.018
PMid:16338024
Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, et al. (2006). Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 131: 1743-1751.
http://dx.doi.org/10.1053/j.gastro.2006.09.020
PMid:17087951
Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, et al. (2007). Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46: 254-265.
http://dx.doi.org/10.1002/hep.21698
PMid:17596850
Lovicu M, Dessi V, Zappu A, De VS, et al. (2003). Efficient strategy for molecular diagnosis of Wilson disease in the sardinian population. Clin. Chem. 49: 496-498.
http://dx.doi.org/10.1373/49.3.496
PMid:12600964
Luan J, Yuan J, Li X, Jin S, et al. (2009). Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin. Chem. 55: 1503-1509.
http://dx.doi.org/10.1373/clinchem.2009.124859
PMid:19541863
Moskovitz DN, Osiowy C, Giles E, Tomlinson G, et al. (2005). Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance. J. Viral. Hepat. 12: 398-404.
http://dx.doi.org/10.1111/j.1365-2893.2005.00613.x
PMid:15985011
Ohishi W, Shirakawa H, Kawakami Y, Kimura S, et al. (2004). Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. J. Med. Virol. 72: 558-565.
http://dx.doi.org/10.1002/jmv.20026
PMid:14981758
Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, et al. (2006). Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J. Clin. Microbiol. 44: 1994-1997.
http://dx.doi.org/10.1128/JCM.02477-05
PMid:16757589 PMCid:1489409
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, et al. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45: 529-538.
http://dx.doi.org/10.1016/j.jhep.2006.05.013
PMid:16879891
Santantonio T, Fasano M, Durantel S, Barraud L, et al. (2009). Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antivir. Ther. 14: 557-565.
PMid:19578241
Tran N, Berne R, Chann R, Gauthier M, et al. (2006). European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes. J. Clin. Microbiol. 44: 2792-2800.
http://dx.doi.org/10.1128/JCM.00295-06
PMid:16891494 PMCid:1594645
Villet S, Pichoud C, Billioud G, Barraud L, et al. (2008). Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J. Hepatol. 48: 747-755.
http://dx.doi.org/10.1016/j.jhep.2008.01.027
PMid:18331765
Wang YZ, Xiao JH, Ruan LH, Zhang HY, et al. (2009). Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay. Clin. Chim. Acta 408: 70-74.
http://dx.doi.org/10.1016/j.cca.2009.07.016
PMid:19651117
Zhao Y, Zhang XY, Guo JJ, Zeng AZ, et al. (2010). Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay. J. Clin. Microbiol. 48: 3690-3697.
http://dx.doi.org/10.1128/JCM.00741-10
PMid:20720032 PMCid:2953110